Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 12/2015

01-12-2015 | Capsule Commentary

Capsule Commentary on Binswanger et al., Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff

Author: Jeffrey L. Jackson, MD, MPH

Published in: Journal of General Internal Medicine | Issue 12/2015

Login to get access

Excerpt

More people in the US die from overdose due to prescription opioids than from street drugs.1 The rise in mortality rates has paralleled increased opiate use over the last decade.2 There have been a number of responses, locally and nationally. “Safe” opiate prescribing includes screening patients for opiate risk, keeping opiate doses as low as possible, not combining them with benzodiazepines, requiring patients to sign opiate consent agreements, and performing regular urine monitoring. Most states have prescription drug monitoring programs. Several opiates have been reformulated to make them harder to misuse, and some formularies have dropped higher-risk opiates. …
Literature
1.
Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15(9):618–27.CrossRefPubMed
2.
Centers for Disease Control and Prevention (CDC). Unintentional poisoning deaths--United States, 1999-2004. MMWR Morb Mortal Wkly Rep. 2007;56(5):93-–6.
3.
Kim D, Irwin KS, Khoshnood K. Expanded Access to Naloxone: Options for Critical Response to the Epidemic of Opioid Overdose Mortality. Am J Public Health. 2009;99(3):402–407.PubMedCentralCrossRefPubMed
4.
Pharmacy Benefits Management EZ Minutes. 2014; 12(3): 3.
5.
Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff. J Gen Intern Med 2015 (Article SPI #3394).
Metadata
Title
Capsule Commentary on Binswanger et al., Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff
Author
Jeffrey L. Jackson, MD, MPH
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3437-9

Other articles of this Issue 12/2015

Journal of General Internal Medicine 12/2015 Go to the issue

Capsule Commentary

Capsule Commentary on McNeely et al., Validation of Self-Administered Single Item Screening Questions (SISQs) for Unhealthy Alcohol and Drug use in Primary Care Patients

Capsule Commentary

Capsule Commentary on Al-Khatib et al., Future Research Prioritization: Implantable Cardioverter Defibrillator Therapy in Older Patients

Original Research

Medical School Experiences Associated with Change in Implicit Racial Bias Among 3547 Students: A Medical Student CHANGES Study Report

Perspective

Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians

Clinical Practice: Clinical Images

MRSA-Associated Lemierre’s Syndrome in an Intravenous Drug User

Original Research

Underuse and Overuse of Osteoporosis Screening in a Regional Health System: a Retrospective Cohort Study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits